Follow The Filings

BENF Beneficient

Beneficient earnings company data as of 4:48 AM ET 10/23

  • 1 of 1 EPS beats

History

2 periods, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 13 Nov EPS — — —
Rev — — —
FY2027 Q1 14 Aug EPS -2.51 -0.47 Beat
Rev — $12.2M —

Insider trades

Open-market buys and sales by BENF's executives, directors and 10% owners in the last 12 months, from their Form 4s

All BENF insider trades
  • $35K bought by 3 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Peter T Cangany Jr. Director
    Buy
    $20K 18,868 shares at $1.06 +24% to stake
    Traded Sep 15 Filed Sep 17
    ↗
  2. Derek L. Fletcher See Remarks
    Buy
    $5,000 4,717 shares at $1.06 +762% to stake
    Traded Sep 15 Filed Sep 17
    ↗
  3. James G. Silk CEO
    Buy
    $10K 9,434 shares at $1.06 +0.9% to stake
    Traded Sep 15 Filed Sep 17
    ↗

Also filed in the last 12 months, not counted as buying or selling: 14 stock grants.

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
DEF 14A Filing Doc
8-K 1.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 3.02 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 2.03,9.01 Filing Doc
424B3 Filing Doc
S-1 Filing Doc
8-K 3.02,3.03,5.03,7.01,9.01 Filing Doc
DEFA14A Filing Doc
SCHEDULE 13D — Filing Doc
8-K 2.03,9.01 Filing Doc
10-K Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
8-K/A 5.02 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
SCHEDULE 13D/A — Filing Doc
8-K 3.02,3.03,5.03,7.01,9.01 Filing Doc
DEFA14A Filing Doc
424B3 Filing Doc
424B3 Filing Doc
8-K 5.02,5.07,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 2 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.